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(N588K) in the pore forming region of the cardiac Kr channel (KCNH2, HERG). The
mutations dramatically increase IKr leading to heterogeneous abbreviation of action
potential duration and refractoriness and rendering the channel relatively unresponsive to
IKr blockers. Conclusion: Our data point to a novel genetic mechanism responsible for
sudden death in children, infants and young adults. The mutation leads to a heteroge-
neous abbreviation of action potential duration and refractoriness, creating the substrate
for reentrant arrhythmias.
9:30 a.m.
807-2 Selective Inhibition of Human Cardiac Kir2.2 Inward 
Rectifier Channels by Adrenergic Alpha-1a Receptors
Edgar Zitron, Claudia Kiesecker, Sonja Lück, Eberhard Scholz, Dierk Thomas, Sven 
Kathöfer, Volker A.W. Kreye, Wolfgang Schoels, Hugo A. Katus, Christoph A. Karle, 
University of Heidelberg Medical School, Heidelberg, Germany
Background:
Human Kir2.1 and Kir.2.2 potassium channels predominantly contribute to the molecular
basis of the cardiac inwardly rectifying potassium current IK1. Reduction of IK1 (as seen in
Andersen's syndrome and in congestive heart failure) causes delayed afterdepolariza-
tions which may result in premature ventricular beats and ventricular tachycardia. Inhibi-
tion of IK1 via activation of adrenergic alpha-1 receptors is a well-known phenomenon.
However, its molecular basis has not been elucidated yet. Therefore, we investigated the
interaction of alpha-1a receptors with Kir2.1 and Kir2.2 channels in the Xenopus oocyte
expression system.
Methods:
Cloned human adrenergic alpha-1a receptors and human Kir2.1 and Kir2.2 channels
were co-expressed in Xenopus oocytes and pharmacological experiments were per-
formed using the double electrode voltage clamp technique.
Results:
Application of phenylephrin (10 µM) to Xenopus oocytes expressing only Kir2.1 or Kir2.2
channels was without any effect. However, phenylephrin (10 µM) caused a significant
inhibition of Kir2.2 if the channels were co-expressed with adrenergic alpha-1a receptors.
Steady state conditions were reached after 30 minutes and current amplitudes were
reduced by 20 ± 5% compared to control measurements (p<0.05). In contrast, Kir2.1 cur-
rents were not affected by activation of the receptors.
Surprisingly, in Kir2.2 mutant channels lacking all protein kinase C (PKC) consensus
sites, the same effect as in the wild type could be observed.
Conclusion:
Our study demonstrates that adrenergic alpha-1a receptors exert an inhibitory effect on
human Kir2.2, but not Kir2.1 channels. The effect is independent of direct PKC mediated
phosphorylation of the channel protein. These findings elucidate the molecular basis of a
regulatory pathway which may contribute to the generation of ventricular arrhythmias in
congestive heart failure.
9:45 a.m.
807-3 Additional Gene Modifiers Reduce Effectiveness of β-
Blockers in the Long QT Type 1 Syndrome
Atsushi Kobori, Nobuaki Sarai, Wataru Shimizu, Satoshi Matsuoka, Akinori Noma, Toru 
Kita, Minoru Horie, Kyoto University Graduate School of Medicine, Kyoto, Japan, Shiga 
University of Medical Science, Otsu, Japan
Background:β-blockers are widely used to prevent the lethal cardiac events that associ-
ate long QT syndrome (LQTS) especially in KCNQ1-related LQTS (LQT1) patients.
Some LQT1 patients, however, are refractory to this therapy.
Methods and Results: Eighteen symptomatic LQTS patients (12 families) were geneti-
cally diagnosed to have heterozygous KCNQ1 variants and received β-blocker therapy.
Cardiac events recurred in 4 members (3 families) despite the continued therapy during
the mean follow-up period of 70 months. Three of them (2 families) had the same muta-
tion, A341V (KCNQ1), and the other had R243H (KCNQ1). The latter patient took aprind-
ine that seemed to be responsible for the event. Because A341V (KCNQ1) has not been
evaluated in heterologous mammalian expression system, we conducted functional anal-
ysis to investigate severe phenotype using COS7 cells. And we found that A341V
(KCNQ1) is a loss-of-function type mutation (not dominant negative) as well as previous
report in Xenopus oocytes. Further genetic screening revealed that one A341V (KCNQ1)
family cosegregated with S706C (KCNH2) and another with G144S (KCNJ2). Produced
functional outcome of S706C (KCNH2) mutation reduced current density with voltage
shift of activation kinetics. Action potential simulation study was conducted based on the
KYOTO model to estimate influences of additional gene modifiers. In both models mim-
icking LQT1 plus 2 and LQT1 plus 7, incidence of early afterdepolarization increased
compared with LQT1 model under the setting of β adrenergic stimulation.
Conclusion: Multiple mutations in different LQTS-related genes may modify the clinical
characteristics. Expanded gene survey might be required in the LQT1 patients who are
resistant to β-blocker therapy.
10:00 a.m.
807-4 CUG Expansions in a Myotonic Dystrophy Mouse Model 
Cause Cardiac Conduction Abnormalities and 
Pathologic Electrophysiology Findings
Cordula M. Wolf, Megan C. Sherwood, Dorothy Branco, Sita Reddy, Charles I. Berul, 
Children's Hospital, Boston, MA, University of Southern California School of Medicine, 
Los Angeles, CA
Background: Myotonic dystrophy (DM) is caused by a CTG trinucleotide expansion in
the 3’ untranslated region of the DM gene on chromosome 19. To assess the titration of
RNA-binding proteins by expanded RNA CUG sequences on cardiac function, we stud-
ied transgenic mice carrying long and short CTG repeats, expressing the RNA CUG
message at low (TGlow) and high (TGhigh) levels.
Methods: 14 TGhigh, 9 TGlow mice, and 6 age-matched wild-types (WT) underwent ECG
recordings, in vivo electrophysiology studies, and echocardiography.
Results: ECG measurements in sedated mice demonstrated significant PR, QRS and
QT prolongation in TGlow compared to WT mice. Right bundle branch block was seen in
16 of 22 TG versus 1 of 7 WT mice. Programmed pacing revealed inducible atrial fibrilla-
tion (2/19) and ventricular tachycardia (2/19) only in TG mice. Ventricular effective refrac-
tory period was longer in TG (TGlow: 63±9ms, TGhigh: 56±13ms) than in WT mice
(45±6ms, p<0.05). Echocardiography showed hypertrophic appearance only in TGhigh
mice, with a shorter end diastolic diameter and thicker left ventricular posterior wall diam-
eter (p<0.05).
Conclusion: Transgenic mice overexpressing CUG repeats displayed 1o heart block,
infraHisian conduction abnormalities, and arrhythmia vulnerability. These features were
more prominent in TGlow compared to TGhigh mice. Our study supports the hypothesis
that larger CTG expansions are associated with a higher risk of cardiac conduction dis-
ease in DM.
10:15 a.m.
807-5 Extracellular pH Modifies Drug Blockade on the Human 
Ether-A-Go-Go Related Gene (HERG) Channels
Lin Congrong, Ivana Cvetanovic, Vasant Ranade, John C. Somberg, Rush University, 
Chicago, IL
Background: HERG encodes the rapid component of delayed rectifier potassium current
(IKr), which is critical for the repolarization of cardiac action potentials. Significant change
in pH can occur during ischemia and reperfusion, and the effects of pH on IKr could be
an important underlying mechanism for arrhythmias.
Methods: We investigated the effect of external pH on IKr, as well as the influence of
external pH on the effect of IKr inhibition by anti-arrhythmia agents. HERG expressed in
Xenopus oocytes was used as the experimental model.
Results: Extracellular acidification decreased the amplitudes of both relatively small out-
ward currents and the large tail outward currents, while the decay of tail current was
accelerated. The steady state current was decreased by 14.4±6.8%, 19.8±10.4%,
23.8±10.4%, 28.3±10.5%, and the tail current was decreased by 6.7±1.1%, 8.7±2.1%,
13.4±1.5%, and 26.4±3.0% when decreasing pH from 8.0 to 7.4, 7.0, 6.6, and 6.2,
respectively. The effect of acidification and IKr inhibition by quinidine, dofetilide, and azi-
milide was evaluated. There was no additive or synergistic effect between extracellular
pH and antiarrhythmics on HERG. Quinidine 10 µM inhibited HERG tail current by
37.2±4.8% at pH 7.4. This inhibition was increased to 50.9±4.7% when extracellular pH
was 8.0 and decreased to 4.5±1.8% when extracellular pH was 6.2. Dofetilide 0.3 µM
inhibited HERG tail current by 64.4±7.4, 33.5±2.6 and 1.4±2.4% at extracellular pH 8.0,
7.4, and 6.2 respectively. Azimilide 10 µM inhibited HERG tail current by 63.0±3.6,
58.7±2.9 and 17.4±3.2% at extracellular pH 8.0, 7.4, and 6.2 respectively. For quinidine,
dofetilide, and azimilide, one way ANOVA test showed that there was a significant differ-
ence in current block among the different pH groups.
Conclusion: Our data suggests that extracellular acidification reduces HERG current.
The effects of quinidine, dofetilide, and azimilide are decreased at a more acid pH and
the block of IKr enhanced at a more alkaline pH.
ECG measurements in sedated mice
WT TGlow TGhigh One way 
ANOVA, p=
Post hoc Scheffe's 
analysis
SCL (ms) 131±6 142±7 143±19 ns ns
HR (bpm) 457±22 424±20 427±56 ns ns
PR (ms) 35.0±2.8* 41.2±5.5* 37.3±3.4 0.02 *: p=0.03
QRS (ms) 14.0±2.7 16.8±1.8* 13.7±2.5* 0.01 *: p=0.02
QT (ms) 21.7±2.1* 30.0±2.9*° 22.6±3.7° 0.000 *, °: p=0.000
QTc (ms) 19.0±2.2* 25.2±2.5*° 19.1±4.0° 0.000 *, °: p=0.000
